Skip to main content

Hologic Value Stock - Dividend - Research Selection

Hologic

ISIN: US4364401012 , WKN: 879100

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Why Is Idexx (IDXX) Up 0.5% Since Last Earnings Report?

2026-03-04
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Assessing Hologic (HOLX) Valuation As Shares Consolidate Recent One Year Gains

2026-03-02
What Hologic’s Recent Performance Signals for Investors Hologic (HOLX) has drawn fresh attention after a period of steady share moves, with the stock recently closing at US$75.36. That price sits alongside mixed return figures across the past week, month and past 3 months. See our latest analysis for Hologic. For context, Hologic’s 1 year total shareholder return of 18.88% contrasts with relatively muted share price moves more recently. This suggests earlier gains are now being consolidated...

RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout

2026-03-02
RadNet (RDNT) reports record Q4 revenue and adjusted EBITDA, beating estimates and announcing acquisition of Paris-based AI firm Gleamer.

Lumos lifts operating cash flow on FebriDx momentum as 1H FY26 loss widens

2026-02-26
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has reported revenue of US$6.12 million for the six months to December 31, 2025 (1H FY26), down slightly from US$6.31 million a year earlier, as the company progressed multiple FebriDx commercial and regulatory milestones in the US. Product...

HOLX vs. GEHC: Which Women's Health Stock Should You Pick Now?

2026-02-26
GE HealthCare is gaining ground with strong backlog, AI-driven imaging advances and rising service capture, while Hologic's buyout caps near-term upside.

3 Cash-Producing Stocks We Find Risky

2026-02-26
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

2026-02-24
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

J&J Explores $20 Billion-Plus Sale of Orthopedics Unit

2026-02-19
The business, known as DePuy Synthes, could be valued at more than $20 billion in a sale, the people said, asking not to be identified discussing confidential information. J&J is assembling documents and financials for DePuy Synthes before it meets with possible buyers in the coming weeks, the people said. Several large private equity firms are considering teaming up to potentially buy out the unit, they said.

Blackstone Inc (BX) Strikes Big Deal in Women’s Healthcare Space

2026-02-17
Blackstone Inc (NYSE:BX) is one of the best NYSE stocks to buy for the long term. Blackstone Inc (NYSE:BX) led a $10 billion debt investment in the Australian AI infrastructure company Firmus, Reuters reported on February 9. Confirming the deal, Firmus said in a press release on February 9 that it would use the financing […]

How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?

2026-02-16
HOLX's $18.3B Blackstone-TPG buyout nears close after Q1 miss. With shares near a $76 cash offer, the upside for HOLX investors looks dim.